FindTrial
Sign In

Mother and babys SARS-COV-2 antibody levels following COVID vaccination during pregnancy

NEONATAL SARS-COV-2 ANTIBODY LEVELS AND TRANSPLACENTAL ANTIBODY TRANSFER RATIO FOLLOWING COVID VACCINATION DURING PREGNANCY: AN OBSERVATIONAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041520
Enrollment
20
Registered
2022-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any mother who has received either one or two doses of any COVID vaccination during pregnancy

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Cord antibody level and transplacental ratioTimepoint: Day 1- at delivery—

Secondary

MeasureTime frame
Maternal and neonatal morbidities and outcomes, variation in antibody levels based on number of doses, trimester of vaccine administration, interval between last dose and delivery and its typeTimepoint: Day 28—

Countries

India

Contacts

Public ContactDr Usha Devi

Department of Neonatology, Chettinad Hospital and Research Institute

dr.ushaa@gmail.com9962653294

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026